Figure 2.
Development of Rhinoorbitocerebral Mucormycosis (ROCM) in Relation to Coronavirus Disease 2019 (COVID-19).
A: Development of ROCM during COVID-19 hospitalization (n=7). B: Development of ROCM after hospital discharge for COVID-19 (n=17).
Figure 2.
Development of Rhinoorbitocerebral Mucormycosis (ROCM) in Relation to Coronavirus Disease 2019 (COVID-19).
A: Development of ROCM during COVID-19 hospitalization (n=7). B: Development of ROCM after hospital discharge for COVID-19 (n=17).